The global MRI guided neurosurgical ablation market size was estimated at USD 696.4 billion in 2024 and is projected to grow at a CAGR of 7.7% from 2025 to 2030. One of the primary drivers is the continuous innovation in MRI-guided systems, which has led to the development of advanced technologies such as non-cooled laser and focused ultrasound. These advancements have enabled the creation of minimally invasive surgical procedures, resulting in improved patient outcomes and increased demand for these techniques.
As more patients seek effective treatment options, there is a growing need for minimally invasive alternatives that can provide precise and effective results. The increasing prevalence of these conditions is driving the demand for MRI-guided neurosurgical ablation techniques, which offer a promising solution for healthcare providers.
Patients and healthcare providers are recognizing the benefits of these techniques, including reduced recovery times, lower complication rates, and improved patient satisfaction. As a result, there is a significant shift towards adopting MRI-guided neurosurgical ablation methods, which offer a safer and more effective alternative to traditional surgical approaches.
The increasing availability of advanced MRI-guided devices and favorable insurance coverage policies are enhancing accessibility to these treatments. Furthermore, the presence of skilled neurosurgeons and advanced healthcare infrastructure in regions such as North America is supporting the implementation of cutting-edge technologies and driving market growth.
Accessories led the market and accounted for a share of 32.1% in 2024. Accessories play a critical role in enhancing surgical precision and safety during neurosurgical procedures. Essential tools such as curettes, rongeurs, and dissectors facilitate delicate operations, ensuring optimal outcomes. The frequent application of these accessories in surgeries drives the growth of this segment within the market, catering to the needs of healthcare professionals and patients.
MRI guided focused ultrasound systems are expected to experience significant growth over the forecast period, aided by their ability to perform non-invasive procedures with real-time imaging. This technology allows for precise targeting of tissues, minimizing damage to surrounding areas and reducing recovery times. As a result, healthcare providers and patients are attracted to this technology.
The hospitals segment dominated the market with a revenue share of 65.4% in 2024 due to their comprehensive healthcare infrastructure and availability of skilled medical professionals. They are equipped to handle complex neurosurgical cases, providing advanced treatment options. High patient intake for neurological disorders further drives demand for MRI guided neurosurgical ablation systems in hospital settings, where healthcare professionals can provide expert care.
Ambulatory surgical centers (ASCs) are projected to grow at the fastest CAGR of 8.2% over the forecast period. The preference for minimally invasive techniques, which allow quicker recovery and lower complication rates, makes ASCs an appealing choice for patients seeking efficient and effective MRI guided neurosurgical ablation treatments. This trend is expected to continue as ASCs expand their services to meet the growing demand for outpatient care.
North America MRI guided neurosurgical ablation market dominated the global market with a revenue share of 35.0% in 2024. North America is experiencing advanced healthcare infrastructure, high prevalence of neurological disorders, and increasing adoption of minimally invasive procedures. The region’s presence of leading medical institutions, skilled neurosurgeons, and significant investments in medical technology drive market growth.
The MRI guided neurosurgical ablation market in the U.S. dominated the North America MRI guided neurosurgical ablation market with the largest revenue share in 2024. Rising incidence of brain tumors and neurodegenerative diseases act as major factors driving market growth in the country. Government initiatives to improve healthcare access, advancements in MRI technology, and a strong emphasis on minimally invasive surgical techniques enhance the effectiveness and safety of neurosurgical procedures, boosting market demand.
Europe MRI guided neurosurgical ablation market held substantial market share in 2024 due to increasing awareness of neurological health issues, rising incidences of brain tumors, and supportive healthcare policies promoting advanced treatment options. The region’s focus on technological innovation and well-established healthcare systems contribute to its growth in the global market.
The MRI guided neurosurgical ablation market in Germany is expected to grow rapidly in the forecast period, driven by its robust healthcare infrastructure, significant investment in medical technology, and high number of skilled healthcare professionals. The increasing prevalence of neurological disorders and proactive public health initiatives enhance demand for advanced neurosurgical treatments.
Middle East & Africa MRI guided neurosurgical ablation market is expected to register the fastest CAGR of 8.0% in the forecast period, supported by improving healthcare infrastructure, increasing awareness of neurological conditions, and rising investment in advanced medical technologies. The growing prevalence of brain-related disorders and shift towards minimally invasive surgical techniques drive market expansion in this region.
Some key companies operating in the market include Siemens Healthineers AG; Monteris; Profound Medica; Insightec; Medtronic; among others. Key players are driving market growth through technological advancements, product innovation, and strategic initiatives such as collaborations and AI integration, enhancing patient access and treatment precision.
Monteris Medical is at the forefront of MRI-guided neurosurgical ablation with its NeuroBlate System, leveraging laser interstitial thermal therapy (LITT) to treat brain tumors and lesions through minimally invasive techniques that preserve surrounding healthy tissue.
Insightec excels in MRI-guided focused ultrasound technology, providing non-invasive treatments for neurological disorders such as essential tremor and Parkinson’s disease. Their Exablate Neuro system integrates MRI with focused ultrasound to precisely ablate tissue, enhancing patient recovery and minimizing complications.
The following are the leading companies in the MRI guided neurosurgical ablation market. These companies collectively hold the largest market share and dictate industry trends.
View a comprehensive list of companies in the MRI Guided Neurosurgical Ablation Market
In December 2024, Siemens Healthineers launched the Magnetom Flow. MRI platform featuring a 70 cm bore for enhanced patient comfort, sustainability, and improved image quality through advanced artificial intelligence and automation.
In October 2024, Boston Scientific announced FDA approval for the FARAWAVE NAV Ablation Catheter and FARAVIEW Software, enhancing cardiac mapping and visualization for pulsed field ablation procedures within the FARAPULSE™ PFA System.
In June 2024, ClearPoint Neuro announced the full market release of the SmartFrame OR and ClearPoint Prism 3T Laser Therapy System, showcasing the technologies at the ASSFN conference in Nashville.
In January 2024, Insightec announced the launch of Exablate Prime, enhancing the Exablate Neuro platform with improved functionality, safety features, and efficiency for incisionless neurosurgery in movement disorders.
Report Attribute |
Details |
Market size value in 2025 |
USD 748.0 million |
Revenue forecast in 2030 |
USD 1.1 billion |
Growth rate |
CAGR of 7.7% from 2025 to 2030 |
Base year for estimation |
2024 |
Historical data |
2018 - 2023 |
Forecast period |
2025 - 2030 |
Quantitative units |
Revenue in USD million/billion and CAGR from 2025 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, trends |
Segments covered |
Product, end use, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country scope |
U.S., Canada, Mexico, UK, Germany, France, Italy, Spain, Denmark, Sweden, Norway, China, Japan, India, Australia, South Korea, Thailand, Brazil, Argentina, South Africa, Saudi Arabia, UAE, Kuwait |
Key companies profiled |
Siemens Healthineers AG; Monteris; Profound Medica; Insightec; Medtronic; Boston Scientific Corporation; AngioDynamics; ClearPoint Neuro, Inc.; Elekta; Accuray Incorporated |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global MRI guided neurosurgical ablation market report based on product, end use, and region:
Product Outlook (Revenue, USD Million, 2018 - 2030)
MRI Guided RF Ablation Systems
MRI Guided Laser Ablation Systems
MRI Guided Focused Ultrasound Systems
Accessories
End Use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Clinics
Ambulatory Surgical Centers
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."